Document Detail


PTPase inhibition restores ERK1/2 phosphorylation and protects mammary epithelial cells from apoptosis.
MedLine Citation:
PMID:  16176809     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Specific survival signals derived from extracellular matrix (ECM) and growth factors are required for mammary epithelial cell survival. We have previously demonstrated that inhibition of ECM-induced ERK1/2 MAPK pathway with PD98059 leads to apoptosis in primary mouse mammary epithelial cells. In this study, we have further investigated MAPK signal transduction in cell survival of these cells cultured on a laminin rich reconstituted basement membrane. ERK1/2 phosphorylation is activated in the absence of insulin by cell-cell substratum interactions that cause ligand-independent EGFR transactivation. Intact EGFR signal transduction is required for ECM determined cell survival as the EGFR pathway inhibitor, AG1478, induces apoptosis of these cultures. Rescue of AG1478 or PD98059 treated cultures by PTPase inhibition with vanadate restores cellular phospho-ERK1/2 levels and prevents apoptosis. These results emphasize that ERK1/2 phosphorylation and inhibition of PTPase activity are necessary for PMMEC cell survival.
Authors:
Fiona Furlong; Darren Finlay; Finian Martin
Related Documents :
17380299 - The effect of cox-2 inhibitor, nimesulide, on angiogenetic factors in primary endometri...
17884839 - Involvement of insulin-like growth factor-binding protein-related protein 1 in decidual...
7102579 - Morphological studies on long-term culture of marrow cells: characterization of the adh...
6347369 - Comparison of rates of phenotypic variability in surface antigen expression in normal a...
3096799 - Localization of immunoglobulin-containing cells in human endometrium in the first trime...
14518549 - Life cycle of decidual cells.
1710659 - The segmentation of the leech nervous system is prefigured by myogenic cells at the emb...
6371809 - Identification of glial filament protein and vimentin in the same intermediate filament...
7959639 - Heparin-binding egf-like growth factor synthesis by smooth muscle cells.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Biochemical and biophysical research communications     Volume:  336     ISSN:  0006-291X     ISO Abbreviation:  Biochem. Biophys. Res. Commun.     Publication Date:  2005 Nov 
Date Detail:
Created Date:  2005-10-03     Completed Date:  2005-12-12     Revised Date:  2013-06-03    
Medline Journal Info:
Nlm Unique ID:  0372516     Medline TA:  Biochem Biophys Res Commun     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1292-9     Citation Subset:  IM    
Affiliation:
UCD School of Biomolecular and Biomedical Science, Conway Institute, University College Dublin, Belfield, Ireland. fiona.furlong@ucd.ie
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Apoptosis / physiology*
Cell Adhesion
Cell Survival
Cells, Cultured
Epithelial Cells / metabolism,  physiology*
Female
Flavonoids / pharmacology
Insulin / physiology
Laminin / metabolism
Mammary Glands, Animal / cytology*
Mice
Mitogen-Activated Protein Kinase 1 / metabolism*
Mitogen-Activated Protein Kinase 3 / metabolism*
Phosphorylation
Protein Kinase Inhibitors / pharmacology
Protein Tyrosine Phosphatases / antagonists & inhibitors,  metabolism*
Quinazolines
Receptor, Epidermal Growth Factor / metabolism
Tyrphostins / pharmacology
Vanadates / pharmacology
Chemical
Reg. No./Substance:
0/2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one; 0/Flavonoids; 0/Insulin; 0/Laminin; 0/Protein Kinase Inhibitors; 0/Quinazolines; 0/Tyrphostins; 0/Vanadates; 170449-18-0/tyrphostin AG 1478; EC 2.7.10.1/Receptor, Epidermal Growth Factor; EC 2.7.11.24/Mitogen-Activated Protein Kinase 1; EC 2.7.11.24/Mitogen-Activated Protein Kinase 3; EC 3.1.3.48/Protein Tyrosine Phosphatases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Hyperphosphorylated neurofilament NF-H is a serum biomarker of axonal injury.
Next Document:  Effects of repeated infliximab therapy on serum lipid profile in patients with refractory rheumatoid...